Targeting Tumor Heterogeneity by Breaking a Stem Cell and Epithelial Niche Interaction Loop
Advanced Science · 2024
DOI: 10.1002/advs.202307452 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Rongze Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Lab of Rare Pediatric Diseases & Hunan Key Laboratory of Medical Genetics of the School of Life Sciences, Hengyang, Hunan, 421001, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Stem Cell Niche. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
Tumor heterogeneity, the presence of multiple distinct subpopulations of cancer cells between patients or among the same tumors, poses a major challenge to current targeted therapies. The way these different subpopulations interact among themselves and the stromal niche environment, and how such interactions affect cancer stem cell behavior has remained largely unknown. Here, it is shown that an FGF‐BMP7‐INHBA signaling positive feedback loop integrates interactions among different cell populations, including mammary gland stem cells, luminal epithelial and stromal fibroblast niche components not only in organ regeneration but also, with certain modifications, in cancer progression. The reciprocal dependence of basal stem cells and luminal epithelium is based on basal‐derived BMP7 and luminal‐derived INHBA, which promote their respective expansion, and is regulated by stromal‐epithelial FGF signaling. Targeting this interaction loop, for example, by reducing the function of one or more of its components, inhibits organ regeneration and breast cancer progression. The results have profound implications for overcoming drug resistance because of tumor heterogeneity in future targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Lab of Rare Pediatric Diseases & Hunan Key Laboratory of Medical Genetics of the School of Life Sciences, Hengyang, Hunan, 421001, China.
- Institute of Cell Biology, University of South China, Hengyang, Hunan, 421001, China.
- Institute for Future Sciences, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
- School of Life Science and Technology, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, 201210, China.
- The First Affiliated Hospital, Pharmacy Department, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
- CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
ORCID-Profile: Pengfei Lu
Förderung
- National Natural Science Foundation of China
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Ma, R., Feng, D., Chen, J., Zhou, J., Xia, K., Kong, X., Hu, G., & Lu, P. (2024). Targeting Tumor Heterogeneity by Breaking a Stem Cell and Epithelial Niche Interaction Loop. Advanced Science. https://doi.org/10.1002/advs.202307452
Vancouver
Ma R, Feng D, Chen J, Zhou J, Xia K, Kong X, et al. Targeting Tumor Heterogeneity by Breaking a Stem Cell and Epithelial Niche Interaction Loop. Advanced Science. 2024. doi:10.1002/advs.202307452
BibTeX
@article{Ma2024,
author = {Ma, Rongze and Feng, Deyi and Chen, Jing and Zhou, Jiecan and Xia, Kun and Kong, Xiangyin and Hu, Guohong and Lu, Pengfei},
title = {Targeting Tumor Heterogeneity by Breaking a Stem Cell and Epithelial Niche Interaction Loop},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202307452}
}
EUVIMED